Skip to main content
. 2019 Nov 20;25(3):e469–e476. doi: 10.1634/theoncologist.2019-0541

Table 6.

Cox proportional hazard analysis of the risk of overall survival between patients with metastatic colorectal cancer receiving TAS‐102 after propensity score matched analysis

Factor HR (95% CI) p value
Combination with bevacizumab 0.37 (0.16–0.84) .018
Age (IQR: 53.25–73) 1.46 (0.77–2.80) .248
Modified Glasgow prognostic score 1.30 (0.49–3.44) .599

graphic file with name ONCO-25-e469-g009.jpg

Abbreviations: CI, confidence interval; HR, hazard ratio; IQR, interquartile range.